Toll-like receptor 4 (TLR4) – G protein signaling complex (TLR4-G protein complex)

The Toll-like receptor 4 (TLR4) – G protein signaling complex is a specialized molecular assembly that mediates the innate immune system's response to Gram-negative bacteria. While TLR4 is classically known to signal through MyD88 and TRIF adapter proteins, research has demonstrated its ability to interact with heterotrimeric G proteins, such as Gαi and Gαs, to trigger rapid cellular responses (Triantafilou et al., 2001). This complex is particularly significant in the context of neuroinflammation, where it facilitates microglial activation and contributes to the development of chronic neuropathic pain and opioid-induced hyperalgesia (Hutchinson et al., 2012). In systemic conditions like sepsis, the overactivation of this complex by lipopolysaccharide (LPS) leads to the excessive production of pro-inflammatory cytokines, often referred to as a cytokine storm. Therapeutic strategies targeting this complex include TLR4 antagonists like Eritoran and Resatorvid (TAK-242), which aim to block the receptor's activation and subsequent signaling (NIH/NCBI). Additionally, certain non-opioid isomers of naloxone and naltrexone are being investigated for their potential to disrupt this specific signaling pathway to treat pain and addiction without interfering with classical opioid receptors.

Other names

TLR4-G protein signaling assemblyTLR4-Gi/o signaling complexTLR4-GPCR crosstalk complexCD284-G protein complex

Inhibition of TLR4-mediated signaling by preventing the recruitment of G proteins and adapter proteins to the receptor's intracellular domain.